Corporate Finance

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

Indian clean energy giant ReNew posts stellar results, slashing losses and boosting profits, thanks to its booming solar manufacturing division.

With strategic hires and a new focus, Cahill is building a transatlantic team to capture the booming data center and real estate finance market.

Following a successful Thai pilot, the CFD broker is leveraging its AI trading tool to expand into high-growth, but complex, emerging financial landscapes.

Indian startup DUSQ lands ₹24 crore to challenge global sleep-tech giants with a novel platform that promises to restore sleep, not just score it.

Beijing's X-Humanoid launches its new Tien Kung 3.0 robot, aiming to break down industry barriers with a powerful open-source AI and hardware platform.

Backed by $7M, 19-year-old Mike Shperling's Skygen.AI is here to end the chatbot era with autonomous agents that work directly inside your software.

Tokyo-based materials giant DIC is investing $62M in Physical AI, partnering with a Swiss VC to bridge the gap between the digital and physical worlds.

A landmark trial for Roche’s Gazyva shows unprecedented success in treating primary membranous nephropathy, offering hope of preventing kidney failure.

The/Nudge Foundation's the*spark | Pullur Centre opens, a purpose-built space designed to foster collaboration and scale solutions for India's social challenges.

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

Panama finalizes its multi-billion dollar bond tender offer, a strategic move to refinance debt amid fiscal pressures and a changing economic landscape.

The veteran-founded coffee brand is on the clock after its stock price fell below $1.00, triggering a six-month window to brew a market turnaround.

The junior miner's new Shareholder Rights Plan is a defensive maneuver. Is it a sign of confidence, a hint of vulnerability, or a growing industry trend?

With top proxy firms ISS and Glass Lewis on board, Criteo's plan to redomicile and simplify its stock structure is a major play for U.S. investors.

With a new interim CEO and mounting financial pressure, VERSES AI's upcoming investor webinar is a pivotal test of its bio-inspired AI vision.

After a 1,000% stock surge on promising clinical data, Nektar Therapeutics secures $460M, fueling its next chapter in immunotherapy amid high hopes and risks.

The AI and GPU infrastructure firm has adopted a shareholder rights plan, a defensive move to thwart hostile takeovers and control its destiny.

Influential proxy advisors ISS and Glass Lewis urge shareholders to approve the C$36.60 per share cash offer, framing it as a secure exit for investors.

RBC Global Asset Management is overhauling its fund lineup, shifting to quantitative strategies and merging funds. Here’s what it means for investors.